FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976526749> ?p ?o ?g. }

• W1976526749 endingPage "1491" @default.
• W1976526749 startingPage "1475" @default.
• W1976526749 abstract "Several substituted dibenzo[c,h]cinnolines were synthesized and evaluated for their potential to target topoisomerase I and for their relative cytotoxic activity. Select benzo[i]phenanthridines are capable of stabilizing the cleavable complex formed with topoisomerase I and DNA. This study was initiated to examine whether dibenzo[c,h]cinnolines, which are in essence aza analogues of benzo[i]phenanthridines, possess similar pharmacological properties. 2,3-Dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine is one of the more potent benzo[i]phenanthridine derivatives in regard to topoisomerase I-targeting activity and cytotoxicity. The structure-activity relationship observed with these substituted dibenzo[c,h]cinnolines parallels that observed for benzo[i]phenanthridine derivatives. Compared to similarly substituted benzo[i]phenanthridines, the dibenzo[c,h]cinnoline analogues exhibit more potent topoisomerase I-targeting activity and cytotoxicity. The relative IC(50) values obtained in assessing the cytotoxicity of 2,3-dimethoxy-8,9-methylenedioxydibenzo[c,h]cinnoline and 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine in the human lymphoblastma cell line, RPMI8402, are 70 and 400 nM, respectively. In tumor cell lines selected for resistance to camptothecin and known to express mutant topoisomerase I, benzo[i]phenanthridine derivatives were not cross-resistant. In contrast, similarly substituted dibenzo[c,h]cinnolines with significant topoisomerase I-targeting activity did exhibit cross-resistance in these camptothecin-resistant cell lines. The cytotoxicity of these dibenzo[c,h]cinnolines was not diminished in cells overexpressing the efflux transporter, MDR1. These data indicate that substituted dibenzo[c,h]cinnolines can exhibit potent topoisomerase I-targeting activity and are capable of overcoming the multi-drug resistance associated with this efflux transporter." @default.
• W1976526749 created "2016-06-24" @default.
• W1976526749 creator A5019938572 @default.
• W1976526749 creator A5029554853 @default.
• W1976526749 creator A5032798692 @default.
• W1976526749 creator A5057145998 @default.
• W1976526749 creator A5061198316 @default.
• W1976526749 creator A5087761441 @default.
• W1976526749 date "2003-04-01" @default.
• W1976526749 modified "2023-10-16" @default.
• W1976526749 title "Substituted dibenzo[ c,h ]cinnolines: topoisomerase I-targeting anticancer agents" @default.
• W1976526749 cites W1524137609 @default.
• W1976526749 cites W1555798239 @default.
• W1976526749 cites W1629179716 @default.
• W1976526749 cites W1971655268 @default.
• W1976526749 cites W1983995416 @default.
• W1976526749 cites W1985426723 @default.
• W1976526749 cites W1994240050 @default.
• W1976526749 cites W1996610658 @default.
• W1976526749 cites W2002456513 @default.
• W1976526749 cites W2012068735 @default.
• W1976526749 cites W2019672150 @default.
• W1976526749 cites W2022751739 @default.
• W1976526749 cites W2035074423 @default.
• W1976526749 cites W2035561817 @default.
• W1976526749 cites W2053953643 @default.
• W1976526749 cites W2058940094 @default.
• W1976526749 cites W2072946670 @default.
• W1976526749 cites W2075357854 @default.
• W1976526749 cites W2086537368 @default.
• W1976526749 cites W2088188015 @default.
• W1976526749 cites W2088637935 @default.
• W1976526749 cites W2088667337 @default.
• W1976526749 cites W2096712606 @default.
• W1976526749 cites W2102345056 @default.
• W1976526749 cites W2103489107 @default.
• W1976526749 cites W2107751342 @default.
• W1976526749 cites W2114918609 @default.
• W1976526749 cites W2124021652 @default.
• W1976526749 cites W2160948762 @default.
• W1976526749 cites W2332552204 @default.
• W1976526749 cites W261007534 @default.
• W1976526749 cites W2952979912 @default.
• W1976526749 cites W4233567369 @default.
• W1976526749 doi "https://doi.org/10.1016/s0968-0896(02)00604-1" @default.
• W1976526749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12628673" @default.
• W1976526749 hasPublicationYear "2003" @default.
• W1976526749 type Work @default.
• W1976526749 sameAs 1976526749 @default.
• W1976526749 citedByCount "80" @default.
• W1976526749 countsByYear W19765267492012 @default.
• W1976526749 countsByYear W19765267492013 @default.
• W1976526749 countsByYear W19765267492014 @default.
• W1976526749 countsByYear W19765267492015 @default.
• W1976526749 countsByYear W19765267492016 @default.
• W1976526749 countsByYear W19765267492017 @default.
• W1976526749 countsByYear W19765267492018 @default.
• W1976526749 countsByYear W19765267492019 @default.
• W1976526749 countsByYear W19765267492020 @default.
• W1976526749 countsByYear W19765267492021 @default.
• W1976526749 countsByYear W19765267492022 @default.
• W1976526749 countsByYear W19765267492023 @default.
• W1976526749 crossrefType "journal-article" @default.
• W1976526749 hasAuthorship W1976526749A5019938572 @default.
• W1976526749 hasAuthorship W1976526749A5029554853 @default.
• W1976526749 hasAuthorship W1976526749A5032798692 @default.
• W1976526749 hasAuthorship W1976526749A5057145998 @default.
• W1976526749 hasAuthorship W1976526749A5061198316 @default.
• W1976526749 hasAuthorship W1976526749A5087761441 @default.
• W1976526749 hasConcept C109316439 @default.
• W1976526749 hasConcept C147897179 @default.
• W1976526749 hasConcept C155647269 @default.
• W1976526749 hasConcept C185592680 @default.
• W1976526749 hasConcept C193042331 @default.
• W1976526749 hasConcept C202751555 @default.
• W1976526749 hasConcept C2776061638 @default.
• W1976526749 hasConcept C2779682216 @default.
• W1976526749 hasConcept C2780185047 @default.
• W1976526749 hasConcept C552990157 @default.
• W1976526749 hasConcept C55493867 @default.
• W1976526749 hasConcept C71240020 @default.
• W1976526749 hasConceptScore W1976526749C109316439 @default.
• W1976526749 hasConceptScore W1976526749C147897179 @default.
• W1976526749 hasConceptScore W1976526749C155647269 @default.
• W1976526749 hasConceptScore W1976526749C185592680 @default.
• W1976526749 hasConceptScore W1976526749C193042331 @default.
• W1976526749 hasConceptScore W1976526749C202751555 @default.
• W1976526749 hasConceptScore W1976526749C2776061638 @default.
• W1976526749 hasConceptScore W1976526749C2779682216 @default.
• W1976526749 hasConceptScore W1976526749C2780185047 @default.
• W1976526749 hasConceptScore W1976526749C552990157 @default.
• W1976526749 hasConceptScore W1976526749C55493867 @default.
• W1976526749 hasConceptScore W1976526749C71240020 @default.
• W1976526749 hasIssue "7" @default.
• W1976526749 hasLocation W19765267491 @default.
• W1976526749 hasLocation W19765267492 @default.
• W1976526749 hasOpenAccess W1976526749 @default.
• W1976526749 hasPrimaryLocation W19765267491 @default.

• next